DaVita Clinical Research
DaVita Clinical Research, formerly Total Renal Research, Inc., is a clinical trial company which conducts Phase I and II studies and manages a network of trial sites that operate Phase II-IV clinical trials.[1] It is a wholly owned subsidiary of DaVita, Inc.. It has trial sites in North America and Europe.[2] DaVita Clinical Research works with CROs and manufacturers on clinical trials.[3]
History
DaVita Clinical Research was founded in 1985 in a hospital-based facility at Hennepin County Medical Center in Minneapolis, MN.[4] In 2012, DaVita Clinical Research partnered with St. Anthony Medical Campus to establish a hospital-based research facility containing 80 beds, which increased the company's trial capacity from 42 to 122 beds in North America.[5][6]
DaVita Clinical Research merged with HealthCare Partners Clinical Research, which was acquired by DaVita, Inc. in 2012 for $4.4 billion, in December 2014.[7][4]
In August 2016, DaVita Clinical Research announced a global strategic alliance with Quintiles to optimize end-to-end support for renal disease clinical trials.[2][8]
References
- ↑ Jack W. Plunkett (2005). Plunkett’s Health Care Industry Almanac 2006. Plunkett Research, Ltd.
- 1 2 "Quintiles, DaVita Clinical Research partner". CenterWatch. 2016.
- ↑ "DaVita highlights its full-service pharmacy for renal-disease patients". Pharmaceutical Commerce. 2014.
- 1 2 Damian Garde (2014). "DaVita grows its in-house CRO with a data-centric merger". FierceBiotech.
- ↑ Steve Raabe (2012). "DaVita to open kidney research center at St. Anthony medical campus in Lakewood". Denver Post.
- ↑ "DaVita Clinical Research Expands in Denver". DDD Magazine. 2012.
- ↑ Michael Essany (2014). "DaVita Healthcare Partners Merges Two if its Research Organizations". mHealthWatch.
- ↑ Melissa Fassbender (2016). "Quintiles and DaVita Clinical Research announce strategic alliance". Outsourcing-Pharma.